We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Neomorph Stock

Invest in or calculate the value of your shares in Neomorph or other pre-IPO companies through EquityZen's platform.

Get Started

Neomorph Stock

Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.

About Neomorph Stock

Founded

2020

Headquarters

San Diego, CA, US

Industries

Software, Artificial Intelligence, Data and Analytics

Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments. The company designs molecular strategies that induce proximity between proteins to enable selective degradation through natural cellular pathways. Its work focuses on discovering compounds that can modulate protein function by removing or altering specific targets within cells. The organization applies computational design, structural biology, and chemical biology to support drug discovery efforts. It advances programs across multiple therapeutic areas where controlled protein degradation may provide new treatment options.

Neomorph Management

Leadership team at Neomorph

Founder

Benjamin Ebert

Founder

Scott Armstrong

Locked Features

Join now and verify your accreditation status to gain access to:

  • Neomorph Current Valuation
  • Neomorph Stock Price
  • Neomorph Management
  • Available deals in Neomorph and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Neomorph Cap Table and Funding History by Share Class and Liquidity Preferences
    • Neomorph Revenue and Financials
    • Neomorph Highlights
    • Neomorph Business Model
    • Neomorph Risk Factors
  • Neomorph Research Report from SACRA Research
Join Now

Trading Neomorph Stock

How to invest in Neomorph stock?

Accredited investors can buy pre-IPO stock in companies like Neomorph through EquityZen funds. These investments are made available by existing Neomorph shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.

How to sell Neomorph stock?

Shareholders can sell their Neomorph stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Neomorph